Search

everythinglearnresearchcommunity

for

Search:↓

Centratherum anthelminticum seed extract effectively treats Polycystic Ovary Syndrome in rats.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

New tools show that in fish, NPY increases feeding and somatostatin decreases it.

Agaricus subrufescens improves ovarian function and biochemical health in rats with PCOS.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

Losing weight, possibly through bariatric surgery, is key to improving PCOS and hyperandrogenism symptoms in obese patients.

Overexpressing a specific enzyme in mice causes hair loss and female infertility.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

PCOS increases sexual pain distress in infertile women.

Eating healthy and exercising can help manage Polycystic Ovarian Syndrome and its related health problems.

The document concludes that PCOS in adolescents is complex and requires comprehensive care to manage its symptoms and associated health risks.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Adult female acne requires a comprehensive treatment approach, including medical options and lifestyle changes, with attention to psychological well-being.

Inositol was more effective than metformin in improving menstrual cycles and pregnancy rates in PCOS patients.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

Chromium salts may help with insulin sensitivity in PCOS, but more research is needed to confirm their overall effectiveness and safety.

The document concludes that Syndromes of Severe Insulin Resistance are rare disorders with limited treatment options.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Diagnosing PCOS in teenagers is hard because its symptoms often look like normal puberty, and there's a need for better diagnosis methods and agreement on criteria.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.